Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease
- 14 August 2023
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 44 (4) , 799-813
Abstract
No abstract availableKeywords
Funding Information
- RedHill Biopharma
- University of British Columbia
- AstraZeneca
- Esperion Therapeutics
This publication has 71 references indexed in Scilit:
- Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010Emerging Infectious Diseases, 2013
- Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapyJournal of Antimicrobial Chemotherapy, 2012
- Clinical relevance ofMycobacterium malmoenseisolation in the NetherlandsEuropean Respiratory Journal, 2009
- Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east FranceThorax, 2009
- Long-term relapses after 12-month treatment forMycobacterium kansasiilung diseaseEuropean Respiratory Journal, 2008
- Pulmonary Nontuberculous Mycobacterial DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Outcomes of a Standardized Triple‐Drug Regimen for the Treatment of Nontuberculous Mycobacterial Pulmonary InfectionClinical Infectious Diseases, 2008
- Clinical relevance ofMycobacterium simiaein pulmonary samplesEuropean Respiratory Journal, 2007
- Pulmonary disease caused byM. malmoensein HIV negative patients: 5‐yr follow-up of patients receiving standardised treatmentEuropean Respiratory Journal, 2003
- Mycobacterium aviumresists exposure to the acidic conditions of the stomachFEMS Microbiology Letters, 2000